Effect of Antioxidant Mineral Elements Supplementation in the Treatment of Hypertension in Albino Rats

Table 2

Effect of antioxidant minerals on lipid profile and atherogenic index.

Group	TC (mg/dL)	TG (mg/dL)	HDL-C (mg/dL)	LDL-C (mg/dL)	VLDL-C (mg/dL)	AI
I	78.08±4.03	63.89±5.17	40.44±5.30	24.53±4.85	12.77±1.03	0.61±0.16
II	123.64±7.47^𝜌	121.10±12.14^𝜌	30.36±2.23^𝜌	69.05±5.83^𝜌	24.21±2.42^𝜌	2.27±0.20^𝜌
III	109.82±3.43^𝛽,𝜌	70.87±4.63^𝛼	41.45±2.74^𝛼,𝜌	54.18±3.14^𝛼	14.17±0.92^𝛼	1.30±0.11^𝛼,𝜌
IV	108.38±5.18^𝛼,𝜌	65.97±4.76^𝛼	39.98±6.42^𝛼	55.26±5.96^𝛽,𝜌	13.18±0.95^𝛼	1.39±0.36^𝛼,𝜌
V	102.19±11.64^𝛼,𝜌	83.50±8.33^𝛼,𝜌	38.05±3.12^𝛽	46.69±10.9^𝛼,𝜌	16.69±1.66^𝛼,𝜌	1.23±0.33^𝛼,𝜌
VI	94.02±5.24^𝛼,𝜌	80.02±12.06^𝛼,𝛾	41.14±1.23^𝛼	36.86±5.40^𝛼,𝛾	16.00±2.41^𝛼,𝛾	0.89±0.14^𝛼

TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, VLDL-C: very low density lipoprotein cholesterol, AI: atherogenic index, I: normotensive control, II: hypertensive control, III: group treated with copper, IV: group treated with manganese, V: group treated with zinc, and VI: group treated with all the minerals.
Values are expressed as Mean ± SD; 𝑛=5. ^𝛼𝑃<0.01 when compared with group II, ^𝛽𝑃<0.05 when compared with grp II, ^𝜌𝑃<0.01 when compared with group I, and ^𝛾𝑃<0.05 when compare with group I by Dunnette’s multiple comparison test.